Short answer
BALCHEM CORP (BCPC) filed an 8-K current report with the SEC on October 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Earnings report covers quarter ended September 30, 2026.
BALCHEM CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings report covers quarter ended September 30, 2026
- Full financial results and management commentary contained in Exhibit 99.1
- Release issued October 23, 2026, providing the latest operating update to investors
Item EX-99.1 · Exhibit EX-99.1
- Q3 FY2026 sales $290.7M, up 8.6%, with record quarterly net earnings $46.7M and adjusted EBITDA $80.3M, up 12.4%
- GAAP EPS $1.46 versus $1.24, while adjusted EPS reached $1.57 versus $1.35
- Human Nutrition sales $188.2M, up 8.1%, and operating earnings $45.6M, up 11.8%, the primary growth engine
- Animal Nutrition operating earnings surged 82.8% to $6.8M on 11.7% sales growth, signaling substantial segment margin improvement
- Capital returns remained aggressive: $27.4M of Q3 repurchases, with net debt $57.7M and leverage only 0.2 times
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other BALCHEM CORP 8-K filings
Get the next BCPC 8-K as it lands
Follow BCPC for push alerts, or ask the research agent what this filing means.